Literature DB >> 18538050

The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure.

S Kocabas1, D Yedicocuklu, F Z Askar.   

Abstract

BACKGROUND AND OBJECTIVES: The elderly represent a wide and increasing patient population and significant numbers of elderly patients have chronic renal disease. This study aimed to investigate the neuromuscular effects of 0.6 mg kg(-1) rocuronium under propofol anaesthesia in young adults and elderly patients with or without renal failure.
METHODS: The neuromuscular effects of rocuronium 0.6 mg kg(-1) under propofol anaesthesia were investigated in 40 patients with renal failure undergoing arteriovenous shunt surgery, of whom 20 were young adults (18-50 yr) and 20 were elderly (>65 yr) and in 40 patients with normal renal function undergoing peripheral venous surgery, of whom 20 were young adults and 20 were elderly. Neuromuscular transmission was monitored using acceleromyography. The times to recovery of the twitch (T1) to 25%, 50%, 75% and 90% and of the train-of-four ratio to 70%, and the recovery index were recorded.
RESULTS: The times to recovery of the first twitch to 25%, 50%, 75% and 90% and train-of-four to 70% and recovery index were found to be prolonged in both young and elderly patients with renal failure compared to those with normal renal function (e.g. T1 25%: 58.4 +/- 20.2 and 80.1 +/- 23.7 min vs. 32.8 +/- 5.6 and 46.3 +/- 9.0 min, respectively) (P < 0.05). These parameters were also prolonged in the elderly when compared with young adults in both the renal failure and the non-renal failure groups.
CONCLUSIONS: The neuromuscular effects of 0.6 mg kg(-1) rocuronium under propofol anaesthesia were markedly prolonged in young and elderly renal failure patients compared to patients with normal renal function, and also in elderly patients with normal renal function compared with young adults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538050     DOI: 10.1017/S0265021508004717

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  5 in total

1.  Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats.

Authors:  Lonneke M Staals; Hans D de Boer; Jan van Egmond; Frank Hope; Francien van de Pol; Anton H Bom; Jacques J Driessen; Leo H D J Booij
Journal:  J Anesth       Date:  2011-01-12       Impact factor: 2.078

2.  Sugammadex rescue following prolonged rocuronium neuromuscular blockade with 'recurarisation' in a patient with severe renal failure.

Authors:  Steven Lobaz; Mario Sammut; Anand Damodaran
Journal:  BMJ Case Rep       Date:  2013-02-07

3.  Effect of ulinastatin on the rocuronium-induced neuromuscular blockade.

Authors:  Min Soo Kim; Jung Woo Park; Yun Hee Lim; Byung Hoon Yoo; Jun Heum Yon; Dong Won Kim
Journal:  Korean J Anesthesiol       Date:  2012-03-21

4.  Influence of obstructive jaundice on pharmacodynamics of rocuronium.

Authors:  Zhen-Meng Wang; Peng Zhang; Mi-Jia Lin; Bo Tan; Hai-Bo Qiu; Wei-Feng Yu
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

5.  Considerations in Neuromuscular Blockade in the ICU: A Case Report and Review of the Literature.

Authors:  Jessica D Workum; Stephanie H V Janssen; Hugo R W Touw
Journal:  Case Rep Crit Care       Date:  2020-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.